LEADER 00722nam0 2200253   450 
001 9910999495803321
005 20250508155645.0
010   $a9783031619427
100   $a20250508d2024----km y0itay50      ba
101 0 $aeng
102   $aCH
105   $ay       001yy
200 1 $a<<The >>COVID-19 aftermath$evolume II: lessons learned$fNima Rezaei
210   $aCham$cSpringer$d2024
215   $aXI, 369 p.
225 1 $aAdvances in experimental medicine and biology$v1458
700  1$aRezaei,$bNima$0913363
801  0$aIT$bUNINA$gREICAT$2UNIMARC
901   $aBK
912   $a9910999495803321
952   $a150.3365 REZN 01$b2025/81$fFLFBC
959   $aFLFBC
996   $aCOVID-19 aftermath$94374516
997   $aUNINA